Windlas Biotech Limited (NSE:WINDLAS)
India
· Delayed Price · Currency is INR 899.05
-2.20 (-0.24%)
Jul 4, 2025, 3:30 PM IST
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 18.88 billion as of July 3, 2025. Its market cap has increased by 28.79% in one year.
Market Cap
18.88B
Enterprise Value
16.81B
Revenue
7.60B
Ranking
n/a
PE Ratio
31.29
Stock Price
899.05
Market Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 18.88B, an increase of 112.75%. That is a compound annual growth rate of 21.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 4, 2025 | 18.88B | -13.24% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,022.01B |
| Divi's Laboratories | 1,833.46B |
| Cipla | 1,222.30B |
| Apollo Hospitals Enterprise | 1,086.08B |
| Zydus Lifesciences | 1,007.24B |
| Mankind Pharma | 1,006.85B |
| Aurobindo Pharma | 691.91B |
| Fortis Healthcare | 609.29B |